By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Biotricity, Inc.

Biotricity, Inc. (BTCY)

OTC Currency in USD
$0.54
-$0.03
-5.26%
Last Update: 29 Aug 2025, 19:34
$14.35M
Market Cap
-1.13
P/E Ratio (TTM)
Forward Dividend Yield
$0.19 - $0.83
52 Week Range

BTCY Stock Price Chart

Explore Biotricity, Inc. interactive price chart. Choose custom timeframes to analyze BTCY price movements and trends.

BTCY Company Profile

Discover essential business fundamentals and corporate details for Biotricity, Inc. (BTCY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

16 Feb 2018

Employees

55.00

CEO

Waqaas Al-Siddiq

Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Financial Timeline

Browse a chronological timeline of Biotricity, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 16 Feb 2026

Upcoming earnings on 13 Nov 2025

EPS estimate is -$0.08, while revenue estimate is $3.90M.

Earnings released on 14 Aug 2025

EPS came in at -$0.03 surpassing the estimated -$0.09 by +66.67%, while revenue for the quarter reached $3.87M , missing expectations by -0.67%.

Earnings released on 15 Jul 2025

EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%, while revenue for the quarter reached $3.70M , missing expectations by -2.56%.

Earnings released on 19 Feb 2025

EPS came in at -$0.05 surpassing the estimated -$0.11 by +54.55%, while revenue for the quarter reached $3.62M , beating expectations by +0.53%.

Earnings released on 14 Nov 2024

EPS came in at -$0.07 , while revenue for the quarter reached $3.27M .

Earnings released on 19 Aug 2024

EPS came in at -$0.49 , while revenue for the quarter reached $3.20M .

Earnings released on 26 Jun 2024

EPS came in at -$0.47 falling short of the estimated -$0.36 by -30.56%, while revenue for the quarter reached $3.18M , missing expectations by -0.68%.

Earnings released on 20 Feb 2024

EPS came in at -$0.34 surpassing the estimated -$0.41 by +17.07%, while revenue for the quarter reached $2.97M , missing expectations by -7.09%.

Earnings released on 14 Nov 2023

EPS came in at -$0.44 falling short of the estimated -$0.34 by -29.41%, while revenue for the quarter reached $2.89M , missing expectations by -12.38%.

Earnings released on 14 Aug 2023

EPS came in at -$0.07 surpassing the estimated -$0.41 by +82.93%, while revenue for the quarter reached $3.02M , missing expectations by -2.56%.

Stock split effective on 3 Jul 2023

Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 29 Jun 2023

EPS came in at -$0.54 matching the estimated -$0.54, while revenue for the quarter reached $2.74M , missing expectations by -13.21%.

Earnings released on 14 Feb 2023

EPS came in at -$0.54 matching the estimated -$0.54, while revenue for the quarter reached $2.46M , missing expectations by -5.42%.

Earnings released on 14 Nov 2022

EPS came in at -$0.54 falling short of the estimated -$0.48 by -12.50%, while revenue for the quarter reached $2.38M , missing expectations by -6.20%.

Earnings released on 15 Aug 2022

EPS came in at -$0.60 surpassing the estimated -$0.78 by +23.08%, while revenue for the quarter reached $2.06M , missing expectations by -6.02%.

Earnings released on 14 Jul 2022

EPS came in at -$0.72 falling short of the estimated -$0.60 by -20.00%, while revenue for the quarter reached $2.15M , beating expectations by +2.00%.

Earnings released on 14 Feb 2022

EPS came in at -$0.90 matching the estimated -$0.90, while revenue for the quarter reached $1.93M , missing expectations by -8.20%.

Earnings released on 4 Nov 2021

EPS came in at -$0.78 falling short of the estimated -$0.54 by -44.44%, while revenue for the quarter reached $1.81M , missing expectations by -9.63%.

Earnings released on 16 Aug 2021

EPS came in at -$0.48 surpassing the estimated -$0.54 by +11.11%, while revenue for the quarter reached $1.76M , missing expectations by -11.79%.

Earnings released on 21 Jun 2021

EPS came in at -$0.90 , while revenue for the quarter reached $1.19M .

Earnings released on 16 Feb 2021

EPS came in at -$0.66 , while revenue for the quarter reached $1.00M .

Earnings released on 17 Nov 2020

EPS came in at -$0.48 , while revenue for the quarter reached $451.90K .

Earnings released on 13 Nov 2020

EPS came in at -$0.48 , while revenue for the quarter reached $744.59K .

BTCY Stock Performance

Access detailed BTCY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run